ENTRY       D08421                      Drug
NAME        Procainamide (INN)
FORMULA     C13H21N3O
EXACT_MASS  235.1685
MOL_WEIGHT  235.3253
CLASS       Cardiovascular agent
             DG01653  Antiarrhythmics
              DG01652  Class I antiarrhythmic agent
               DG01649  Class Ia antiarrhythmic agent
            Metabolizing enzyme substrate
             DG02928  NAT substrate
            Transporter substrate
             DG02858  SLC22A1 substrate
             DG02854  SLC22A2 substrate
             DG02964  SLC47A1 substrate
             DG03002  SLC47A2 substrate
REMARK      Same as: C07401
            ATC code: C01BA02
            Chemical structure group: DG00193
            Product (DG00193): D00477<JP/US>
EFFICACY    Antiarrhythmic, Sodium channel blocker
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
  PATHWAY   hsa04261(6331)  Adrenergic signaling in cardiomyocytes
            hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: NAT [HSA:9 10]
            Transporter: SLC22A1 [HSA:6580], SLC22A2 [HSA:6582], SLC47A1 [HSA:55244], SLC47A2 [HSA:146802]
INTERACTION  
STR_MAP     map07037  Antiarrhythmic drugs
            map07213  Dopamine receptor agonists/antagonists
            map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BA Antiarrhythmics, class Ia
                 C01BA02 Procainamide
                  D08421  Procainamide (INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               DG01652  Class I antiarrhythmic agent
                DG01649  Class Ia antiarrhythmic agent
                 DG00193  Procainamide
                  D08421  Procainamide
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00193  Procainamide
                D08421  Procainamide
             Transporter substrate
              DG02858  SLC22A1 substrate
               DG00193  Procainamide
                D08421  Procainamide
              DG02854  SLC22A2 substrate
               DG00193  Procainamide
                D08421  Procainamide
              DG02964  SLC47A1 substrate
               DG00193  Procainamide
                D08421  Procainamide
              DG03002  SLC47A2 substrate
               DG00193  Procainamide
                D08421  Procainamide
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D08421  Procainamide (INN)
                SCN2A
                 D08421  Procainamide (INN)
                SCN3A
                 D08421  Procainamide (INN)
                SCN4A
                 D08421  Procainamide (INN)
                SCN5A
                 D08421  Procainamide (INN)
                SCN8A
                 D08421  Procainamide (INN)
                SCN9A
                 D08421  Procainamide (INN)
                SCN10A
                 D08421  Procainamide (INN)
                SCN11A
                 D08421  Procainamide (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D08421
             Drug transporters
              D08421
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D08421
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01653  Antiarrhythmics
               DG01652  Class I antiarrhythmic agent
                DG01649  Class Ia antiarrhythmic agent
                 DG00193  Procainamide
             Metabolizing enzyme substrate
              DG02928  NAT substrate
               DG00193  Procainamide
             Transporter substrate
              DG02858  SLC22A1 substrate
               DG00193  Procainamide
              DG02854  SLC22A2 substrate
               DG00193  Procainamide
              DG02964  SLC47A1 substrate
               DG00193  Procainamide
              DG03002  SLC47A2 substrate
               DG00193  Procainamide
DBLINKS     CAS: 51-06-9
            PubChem: 96025107
            ChEBI: 8428
            LigandBox: D08421
            NIKKAJI: J4.110F
ATOM        17
            1   C8y C    16.1435  -15.8683
            2   C5a C    17.4720  -16.5674
            3   C8x C    16.1436  -14.4001
            4   C8x C    15.0250  -16.4975
            5   N1b N    18.6605  -15.8683
            6   O5a O    17.4721  -17.9656
            7   C8x C    15.0250  -13.7010
            8   C8x C    13.7665  -15.7983
            9   C1b C    19.8490  -16.5674
            10  C8y C    13.7664  -14.4001
            11  C1b C    21.1074  -15.8683
            12  N1a N    12.5780  -13.7010
            13  N1c N    22.2960  -16.5674
            14  C1b C    23.4845  -15.8683
            15  C1b C    22.2960  -17.9656
            16  C1a C    24.7430  -16.5674
            17  C1a C    23.4845  -18.6648
BOND        17
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     4   8 2
            8     5   9 1
            9     7  10 2
            10    9  11 1
            11   10  12 1
            12   11  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17    8  10 1
///
